- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Influenza, Human in New Zealand
Total 1201 results
-
Vir Biotechnology, Inc.Terminated
-
OsivaxNovotech (Australia) Pty Limited; Mater Misericordiae LimitedCompleted
-
GlaxoSmithKlineCompletedInfluenzaAustralia, Singapore
-
Sanofi Pasteur, a Sanofi CompanyCompletedPregnancy | InfluenzaUnited States
-
Sanofi Pasteur, a Sanofi CompanyCompletedPregnancy | InfluenzaUnited States
-
ModernaTX, Inc.Completed
-
GlaxoSmithKlineCompleted
-
ModernaTX, Inc.Active, not recruitingSeasonal InfluenzaUnited States
-
Novartis VaccinesCompletedProphylaxis: InfluenzaUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
Qilu Pharmaceutical Co., Ltd.Unknown
-
Gilead SciencesCompleted
-
Columbia UniversityCenters for Disease Control and PreventionCompleted
-
Vaccitech (UK) LimitedClinical Network Services (CNS) Pty LtdTerminated
-
National Institute of Allergy and Infectious Diseases...Completed
-
SanofiCompletedInfluenza | Swine-origin A/H1N1 InfluenzaUnited States
-
Sanofi Pasteur, a Sanofi CompanyCompletedInfluenzaUnited States, Puerto Rico, Canada
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Hoffmann-La RocheTerminatedInfluenzaUnited States, Israel
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes...CompletedInfluenza and Other Novel Respiratory VirusesUnited States, Chile, United Kingdom, Spain, Argentina, Australia, Thailand, Peru, Germany, Japan, Greece, Belgium, Denmark, Estonia, Poland
-
GlaxoSmithKlineCompletedInfluenzaGermany, United States, Belgium, Norway
-
Emergo Therapeutics, Inc.CompletedInfluenza -Like IllnessUnited States
-
GlaxoSmithKlineCompletedInfluenzaGermany, United States, Belgium, Norway
-
ModernaTX, Inc.Completed
-
SeqirusCompleted
-
Adamas Pharmaceuticals, Inc.CompletedInfluenzaUnited States, Australia, Canada, Netherlands, Singapore
-
Antipodean Pharmaceuticals, Inc.Completed
-
ModernaTX, Inc.CompletedInfluenza | SARS-CoV-2 | RSVUnited Kingdom, Australia, United States
-
Dalhousie UniversityGlaxoSmithKline; Canadian Institutes of Health Research (CIHR); Public Health...Completed
-
Novartis VaccinesCompletedInfluenzaUnited States, Colombia, Panama, Philippines
-
Arbutus Biopharma CorporationRecruitingChronic Hepatitis bNew Zealand
-
Hoffmann-La RocheTerminated
-
Sanofi Pasteur, a Sanofi CompanyCompletedInfluenza | Swine-origin A/H1N1 InfluenzaUnited States
-
GlaxoSmithKlineCompletedInfluenzaGermany, United States, Belgium, Norway
-
Hoffmann-La RocheCompletedInfluenzaAustralia, Hong Kong, United States, France, Germany, Netherlands, Norway, Poland
-
Janssen Research & Development, LLCTerminatedInfluenza AUnited States, France, Korea, Republic of, Taiwan, China, India, Argentina, Israel, Thailand, Vietnam, Hungary, Germany, South Africa, Spain, Turkey, Belgium, Brazil, Canada, Mexico, New Zealand, Bulgaria, Peru, Malaysia, Italy, Estonia, ... and more
-
GlaxoSmithKlineCompleted
-
Arrowhead PharmaceuticalsTerminated
-
ModernaTX, Inc.Active, not recruitingSeasonal InfluenzaUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis C | Chronic Hepatitis C | HCV | CHCNew Zealand
-
Genentech, Inc.CompletedInfluenzaSpain, United Kingdom, Korea, Republic of, Belgium, Czechia, Canada, Netherlands, Hong Kong, New Zealand, Peru, Germany, France, Israel, Hungary, South Africa, Sweden, Mexico, Taiwan, Brazil, Bulgaria, Chile, Italy, Poland, Russian Federation and more
-
Sanofi Pasteur, a Sanofi CompanyTerminatedInfluenza ImmunizationUnited States, Denmark, Poland, Spain
-
National Institute of Allergy and Infectious Diseases...Completed
-
Assembly BiosciencesCompleted
-
Emergent BioSolutionsCompletedInfluenza | Bird FluUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedInfluenza A Virus InfectionUnited States
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
National Institute of Allergy and Infectious Diseases...CompletedInfluenzaUnited States
-
ID Biomedical Corporation, QuebecCompleted
-
ModernaTX, Inc.Active, not recruitingA Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy AdultsInfluenza | SARS-CoV-2United States